This reduction onto MMP9+ motor neurons continued dramatically with ALS progression and was down to 9.94% at P84 compared to age-matched wild-type controls (one-way ANOVA and Dunnett’s post hoc, P = 0.00007; N = 3) (Fig. 1t). This evidence concerns the gene MMP9 and amyotrophic lateral sclerosis.